Journal of Biochemical and Molecular Toxicology,
Journal Year:
2025,
Volume and Issue:
39(4)
Published: April 1, 2025
ABSTRACT
Acute
myeloid
leukemia
(AML)
is
caused
by
altered
maturation
and
differentiation
of
blasts,
as
well
transcriptional/epigenetic
alterations
impaired
apoptosis,
all
which
lead
to
excessive
proliferation
malignant
blood
cells
in
the
bone
marrow.
It
these
mutations
that
cause
tumor
heterogeneity,
linked
a
higher
risk
relapse
death
makes
anti‐AML
treatments
like
HSCT,
chemotherapy,
immunotherapy
(ICI,
CAR
T‐cell‐based
therapies,
cancer
vaccines)
less
effective.
Single‐cell
RNA
sequencing
(scRNA‐seq)
also
it
possible
find
cellular
subclones
profile
tumors,
opens
up
new
diagnostic
therapeutic
targets
for
better
AML
management.
The
HSCT
process
works
when
genetic
transcriptional
information
about
patient
donor
stem
collected.
This
saves
time
lowers
harmful
side
effects
happening
body.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: Nov. 14, 2023
Tumor-associated
macrophages
(TAMs)
are
integral
to
the
tumor
microenvironment
(TME),
influencing
cancer
progression
significantly.
Attracted
by
cell
signals,
TAMs
exhibit
unparalleled
adaptability,
aligning
with
dynamic
milieu.
Their
roles
span
from
promoting
growth
and
angiogenesis
modulating
metastasis.
While
substantial
research
has
explored
fundamentals
of
TAMs,
comprehending
their
adaptive
behavior,
leveraging
it
for
novel
treatments
remains
challenging.
This
review
delves
into
TAM
polarization,
metabolic
shifts,
complex
orchestration
cytokines
chemokines
determining
functions.
We
highlight
complexities
TAM-targeted
focusing
on
adaptability
potential
variability
in
therapeutic
outcomes.
Moreover,
we
discuss
synergy
integrating
TAM-focused
strategies
established
treatments,
such
as
chemotherapy,
immunotherapy.
Emphasis
is
laid
pioneering
methods
like
reprogramming
immunotherapy
adoption
single-cell
technologies
precision
intervention.
synthesis
seeks
shed
light
TAMs’
multifaceted
cancer,
pinpointing
prospective
pathways
transformative
enhancing
modalities
oncology.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(2), P. 1201 - 1201
Published: Jan. 18, 2024
Cancer
stands
as
the
leading
global
cause
of
mortality,
with
rare
cancer
comprising
230
distinct
subtypes
characterized
by
infrequent
incidence.
Despite
inherent
challenges
in
addressing
diagnosis
and
treatment
cancers
due
to
their
low
occurrence
rates,
several
biomedical
breakthroughs
have
led
significant
advancement
both
areas.
This
review
provides
a
comprehensive
overview
state-of-the-art
diagnostic
techniques
that
encompass
new-generation
sequencing
multi-omics,
coupled
integration
artificial
intelligence
machine
learning,
revolutionized
diagnosis.
In
addition,
this
highlights
latest
innovations
therapeutic
options,
immunotherapy,
targeted
therapy,
transplantation,
drug
combination
undergone
clinical
trials
significantly
contribute
tumor
remission
overall
survival
patients.
review,
we
summarize
recent
insights
understanding
pathophysiology,
diagnosis,
modalities,
well
faced
development
data
interpretation
development.
Biology,
Journal Year:
2024,
Volume and Issue:
13(8), P. 638 - 638
Published: Aug. 20, 2024
Depression,
a
significant
mental
health
disorder,
is
under
intense
research
scrutiny
to
uncover
its
molecular
foundations.
Epigenetics,
which
focuses
on
controlling
gene
expression
without
altering
DNA
sequences,
offers
promising
avenues
for
innovative
treatment.
This
review
explores
the
pivotal
role
of
epigenetics
in
depression,
emphasizing
two
key
aspects:
(I)
identifying
epigenetic
targets
new
antidepressants
and
(II)
using
personalized
medicine
based
distinct
profiles,
highlighting
potential
focal
points
such
as
methylation,
histone
structure
alterations,
non-coding
RNA
molecules
miRNAs.
Variations
methylation
individuals
with
depression
provide
opportunities
target
genes
that
are
associated
neuroplasticity
synaptic
activity.
Aberrant
acetylation
may
indicate
antidepressant
strategies
involve
enzyme
modifications.
Modulating
miRNA
levels
can
reshape
depression-linked
expression.
The
second
section
discusses
profiles.
Analyzing
these
patterns
could
identify
biomarkers
treatment
response
susceptibility
facilitating
tailored
treatments
proactive
care.
Addressing
ethical
concerns
regarding
information,
privacy
stigmatization,
crucial
understanding
biological
basis
depression.
Therefore,
researchers
must
consider
issues
when
examining
disorders.
importance
critical
aspect
modern
medical
research.
These
findings
hold
great
novel
medications
treatments,
would
significantly
improve
patient
outcomes,
transform
psychiatry.
As
progresses,
it
expected
more
complex
aspects
processes
enhance
our
comprehension,
increase
effectiveness
therapies.
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Feb. 8, 2025
Abstract
Cancer
is
a
major
global
health
challenge,
with
approximately
19.3
million
new
cases
and
10
deaths
estimated
by
2020.
Laboratory
advancements
in
cancer
detection
have
transformed
diagnostic
capabilities,
particularly
through
the
use
of
biomarkers
that
play
crucial
roles
risk
assessment,
therapy
selection,
disease
monitoring.
Tumor
histology,
single-cell
technology,
flow
cytometry,
molecular
imaging,
liquid
biopsy,
immunoassays,
diagnostics
emerged
as
pivotal
tools
for
detection.
The
integration
artificial
intelligence,
deep
learning
convolutional
neural
networks,
has
enhanced
accuracy
data
analysis
capabilities.
However,
developing
countries
face
significant
challenges
including
financial
constraints,
inadequate
healthcare
infrastructure,
limited
access
to
advanced
technologies.
impact
COVID-19
further
complicated
management
resource-limited
settings.
Future
research
should
focus
on
precision
medicine
early
diagnosis
sophisticated
laboratory
techniques
improve
prognosis
outcomes.
This
review
examines
evolving
landscape
detection,
focusing
breakthroughs
limitations
countries,
while
providing
recommendations
advancing
tumor
resource-constrained
environments.
Cancer Informatics,
Journal Year:
2025,
Volume and Issue:
24
Published: Jan. 1, 2025
Objectives:
Prostate
cancer
stem
cells
(CSCs)
play
an
important
role
in
cell
survival,
proliferation,
metastasis,
and
recurrence;
thus,
removing
CSCs
is
for
complete
removal.
However,
the
mechanisms
underlying
CSC
functions
remain
largely
unknown,
making
it
difficult
to
develop
new
anticancer
drugs
targeting
CSCs.
Herein,
we
aimed
identify
novel
factors
that
regulate
stemness
predict
prognosis.
Methods:
We
reanalyzed
2
single-cell
RNA
sequencing
data
of
prostate
(PCa)
tissues
using
Seurat.
used
gene
set
enrichment
analysis
(GSEA)
estimate
identified
common
upregulated
genes
between
these
datasets.
To
investigate
whether
its
expression
levels
change
over
differentiation,
performed
a
trajectory
monocle
3.
In
addition,
GSEA
helped
us
understand
how
stemness.
Finally,
assess
their
clinical
significance,
Cancer
Genome
Atlas
database
evaluate
impact
on
Results:
The
thioredoxin
(
TXN),
redox
enzyme,
was
approximately
1.2
times
higher
than
PCa
P
<
1
×
10
−10
),
TXN
decreased
differentiation.
suggested
intracellular
signaling
pathways,
including
MYC,
may
be
involved
regulation
by
TXN.
Furthermore,
correlated
with
poor
prognosis
(P
.05)
patients
high
Conclusions:
Despite
limited
sample
size
our
study
need
further
vitro
vivo
experiments
demonstrate
functionally
regulates
CSCs,
findings
suggest
serve
as
therapeutic
target
against
Moreover,
could
useful
marker
predicting
patients.
Computational and Structural Biotechnology Journal,
Journal Year:
2024,
Volume and Issue:
23, P. 954 - 971
Published: Feb. 3, 2024
The
field
of
cancer
genomics
and
transcriptomics
has
evolved
from
targeted
profiling
to
swift
sequencing
individual
tumor
genome
transcriptome.
steady
growth
in
genome,
epigenome,
transcriptome
datasets
on
a
genome-wide
scale
significantly
increased
our
capability
capturing
signatures
that
represent
both
the
intrinsic
extrinsic
biological
features
tumors.
These
differences
can
help
precise
molecular
subtyping
cancer,
predicting
progression,
metastatic
potential,
resistance
therapeutic
agents.
In
this
review,
we
summarized
current
development
genomic,
methylomic,
transcriptomic,
proteomic
metabolic
research
highlighted
their
potentials
clinical
applications
improve
diagnosis,
prognosis,
treatment
decision
patients.
Frontiers in Bioinformatics,
Journal Year:
2024,
Volume and Issue:
4
Published: July 8, 2024
Rapid
advancements
in
high-throughput
single-cell
RNA-seq
(scRNA-seq)
technologies
and
experimental
protocols
have
led
to
the
generation
of
vast
amounts
transcriptomic
data
that
populates
several
online
databases
repositories.
Here,
we
systematically
examined
large-scale
scRNA-seq
databases,
categorizing
them
based
on
their
scope
purpose
such
as
general,
tissue-specific
disease-specific
cancer-focused
cell
type-focused
databases.
Next,
discuss
technical
methodological
challenges
associated
with
curating
along
current
computational
solutions.
We
argue
understanding
including
limitations
assumptions,
is
crucial
for
effectively
utilizing
this
make
robust
discoveries
identify
novel
biological
insights.
Such
platforms
can
help
bridge
gap
between
wet
lab
scientists
through
user-friendly
web-based
interfaces
needed
democratizing
access
data.
These
would
facilitate
interdisciplinary
research,
enabling
researchers
from
various
disciplines
collaborate
effectively.
This
review
underscores
importance
leveraging
approaches
unravel
complexities
offers
a
promising
direction
future
research
field.
Frontiers in Oncology,
Journal Year:
2024,
Volume and Issue:
14
Published: April 22, 2024
Acute
myeloid
leukemia
(AML)
is
a
complex
and
heterogeneous
group
of
aggressive
hematopoietic
stem
cell
disease.
The
presence
diverse
functionally
distinct
populations
cells
within
the
same
patient’s
bone
marrow
or
blood
poses
significant
challenge
in
diagnosing
treating
AML.
A
substantial
proportion
AML
patients
demonstrate
resistance
to
induction
chemotherapy
grim
prognosis
upon
relapse.
rapid
advance
next
generation
sequencing
technologies,
such
as
single-cell
RNA-sequencing
(scRNA-seq),
has
revolutionized
our
understanding
pathogenesis
by
enabling
high-resolution
interrogation
cellular
heterogeneity
ecosystem,
their
transcriptional
signatures
at
level.
New
studies
have
successfully
characterized
inextricably
intertwined
interactions
among
cells,
immune
microenvironment
contributions
development,
therapeutic
These
findings
deepened
broadened
complexity
AML,
which
are
difficult
detect
with
bulk
RNA-seq.
This
review
encapsulates
burgeoning
body
knowledge
generated
through
scRNA-seq,
providing
novel
insights
discoveries
it
unveiled
biology.
Furthermore,
we
discuss
potential
implications
scRNA-seq
opportunities,
focusing
on
immunotherapy.
Finally,
highlight
current
limitations
future
direction
field.
Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Jan. 3, 2025
The
field
of
single
cell
technologies
has
rapidly
advanced
our
comprehension
the
human
immune
system,
offering
unprecedented
insights
into
cellular
heterogeneity
and
function.
While
cryopreserved
peripheral
blood
mononuclear
(PBMC)
samples
enable
deep
characterization
cells,
challenges
in
clinical
isolation
preservation
limit
their
application
underserved
communities
with
limited
access
to
research
facilities.
We
present
CryoSCAPE
(Cryopreservation
for
Scalable
Cellular
And
Proteomic
Exploration),
a
scalable
method
studies
PBMC
multi-omic
assays
using
direct
cryopreservation
whole
blood.
Comparative
analyses
matched
from
density
gradient
demonstrate
efficacy
this
methodology
capturing
proportions
molecular
features.
was
then
optimized
verified
high
sample
throughput
fixed
RNA
sequencing
liquid
handling
automation
batch
60
samples.
Additionally,
demonstrated
be
compatible
functional
assays,
enabling
research.
method,
scalability
cost-effectiveness,
allows
high-throughput
while
minimizing
challenges.
Utilization
clinic
potential
democratize
single-cell
enhance
understanding
function
across
diverse
populations.